Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T23:27:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says the agency will use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T23:15:21.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2; the rest of the page continues to display the same access-denied error.
    Difference
    0.2%
    Check dated 2026-10-19T23:23:24.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T05:55:56.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Access to the study record is blocked, as the page now renders a 403 Forbidden error instead of the study details. The interface shows the 403 message and site footer, with the previous content no longer visible.
    Difference
    19%
    Check dated 2026-09-21T23:57:26.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.6.5 to v3.6.6, indicating a newer version of the page content. This is a metadata update and does not affect the study details or participant information.
    Difference
    0.1%
    Check dated 2026-08-31T18:45:42.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.